24% of GLP-1 users have booked a trip to celebrate a weight loss milestone
As such, it is subject to selection bias and cannot establish causality
Supplementary data The following are the Supplementary data to this article: References 1.Nauck M.A., Mirna A.E.A., Quast D.R
Abstract Glucagon-like peptide 1 (GLP-1) and its receptor GLP-1R are a key component of the satiety signaling system, and long-acting GLP-1 analogs have been approved for the treatment of type-2 diabetes mellitus
Measurement of Reactive Oxygen Species Generation ROS levels were detected by the fluorescent probe 2,7-dichlorofluorescin diacetate (DCFH-DA, Beyotime)
Secrecy is surprisingly common, too: 31% have hidden or downplayed what they spend on a GLP-1 from someone close, including 13% who have kept it from a spouse or partner